相关产品推荐更多 >
![7-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}-3-(4-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}苯基)-4H-苯并吡喃-4-酮,944912-19-0](https://img1.dxycdn.com/2022/1125/060/7615201498534394853-14.jpg!wh200)
7-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}-3-(4-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}苯基)-4H-苯并吡喃-4-酮,944912-19-0
¥2058
(11beta,16alpha,20S)-9-氟-11,20-二羟基-16-甲基-3-氧代孕甾烷-1,4-二烯-21-酸,50764-02-8
¥2205
DL-Phenylethanolamine-d5,1794754-48-5
¥2205
7-氮杂吲哚-5-硼酸频哪醇酯,754214-56-7
¥1470![N-[3-(Dimethylamino)propyl]lauramide-d23 Hydrochloride Salt](https://img1.dxycdn.com/2022/1124/352/2842169574477474853-14.jpg!wh200)
N-[3-(Dimethylamino)propyl]lauramide-d23 Hydrochloride Salt
¥2573
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
- 库存:
99
- 供应商:
爱必信(上海)生物科技有限公司
- CAS号:
2070009-64-0
- 规格:
5mg/2mg
| 规格: | 5mg | 产品价格: | ¥6174.0 |
|---|---|---|---|
| 规格: | 2mg | 产品价格: | ¥4116.0 |
| 公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:GSK2110183 hydrochloride 产品别名:见爱必信官网 英文别名:GSK2110183 hydrochloride 靶点:Akt CAS:2070009-64-0 纯度:98% 外观:见爱必信官网 保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. 描述: GSK2110183 hydrochloride is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively. 溶解性:DMSO : ≥ 36 mg/mL (74.72 mM) 体外研究: GSK2110183 is an ATP competitive, time dependant and fully reversible inhibitors of the Akt kinase family. GSK2110183 has a Ki of 0.08, 2 and 2.6 nM against Akt1, Akt2 and Akt3, respectively. GSK2110183 inhibits the kinase activity of the E17K Akt 1 mutant protein in a standard kinase assay with EC50 of 0.2 nM. 体内研究:Mice bearing BT474 breast tumor xenografts are dosed orally with either vehicle or GSK2110183 at 10, 30 or 100 mg/kg daily for 21 days which result in 8, 37 and 61% TGI, respectively. Mice tolerated GSK2110183 well, with 1-3% body weight loss reported after 5 days of dosing which recover over the course of the study. Other tumor xenograft models which possess an activation of the Akt pathway are explored to further demonstrate compound efficacy. Mice treated with GSK2110183 at 10, 30 and 100 mg/kg result in 23, 37 and 97% TGI, respectively, of SKOV3 xenografts.
产品信息订购:
absin,您身边的科研百宝箱 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料




